MRTN:NASDAQMarten Transport, Ltd. Analysis
Data as of 2026-05-20 - not real-time
$16.13
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Marten Transport (MRTN) is trading at $16.13, comfortably above its 20‑day ($15.12), 50‑day ($13.95) and 200‑day ($12.19) simple moving averages, with the RSI at 68.9 and a bullish MACD crossover (macd_line 0.45 > macd_signal 0.40), suggesting short‑term momentum is intact and the price is holding above the $14.20 support level. However, the stock is markedly overvalued – a trailing P/E of 89.6 versus an industry average of 29, and a discounted cash‑flow fair value of $10.88, leaving the market price roughly 48% above intrinsic estimates. The recent earnings release showed a 33% miss on earnings and a 4% revenue decline, with revenue growth at –8.8% and operating margins near zero, while free cash flow is negative ($‑41.1M) and the dividend payout ratio exceeds 130%, raising concerns about dividend sustainability. In a sector known for cyclicality and regulatory exposure, the combination of high volatility (32% 30‑day), beta above 1, and decreasing volume adds to the risk profile, even as the company benefits from steady demand for temperature‑controlled freight across North America.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish technical indicators (price above SMAs, bullish MACD, RSI near 70)
- Recent earnings and revenue miss indicating earnings volatility
- High valuation metrics (PE far above industry average)
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Significant valuation gap between market price and DCF fair value
- Negative free cash flow and unsustainable dividend payout
- Persistently low profitability margins and declining revenue growth
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Steady demand for temperature‑controlled trucking across the U.S., Canada and Mexico
- Low return on equity and assets indicating limited efficiency gains
- Potential for operational improvements but valuation remains stretched
Key Metrics & Analysis
Financial Health
Revenue Growth-8.80%
Profit Margin1.68%
P/E Ratio89.6
ROE1.89%
ROA0.44%
Debt/Equity0.06
P/B Ratio1.7
Op. Cash Flow$90.3M
Free Cash Flow$-41072000
Industry P/E29.2
Technical Analysis
TrendBullish
RSI68.9
Support$14.20
Resistance$16.22
MA 20$15.12
MA 50$13.95
MA 200$12.19
MACDBullish
VolumeDecreasing
Fear & Greed Index89.18
Valuation
Fair Value$10.88
Target Price$18.00
Upside/Downside11.59%
GradeOvervalued
TypeValue
Dividend Yield1.49%
Risk Assessment
Beta1.10
Volatility32.14%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.